TFX (Teleflex) Current Accrued Expense: $248 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TFX Teleflex Inc TFX
73 GF Score
Price $142.66
GF Value $173.20
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Teleflex Current Accrued Expense?

Teleflex TFX +1.55% 73 Current Accrued Expense is $248 Mil as of Jun. 2026. GuruFocus rates TFX with a GF Score™ of 73/100 and a GF Value™ of $173.20 (Modestly Undervalued). The stock has 9 warning signs investors should review.

Teleflex's Current Accrued Expense for the quarter that ended in Jun. 2026 was $248 Mil.

Teleflex's quarterly Current Accrued Expense declined from Dec. 2025 ($248 Mil) to Mar. 2026 ($238 Mil) but then increased from Mar. 2026 ($238 Mil) to Jun. 2026 ($248 Mil).

Teleflex's annual Current Accrued Expense declined from Dec. 2023 ($299 Mil) to Dec. 2024 ($215 Mil) but then increased from Dec. 2024 ($215 Mil) to Dec. 2025 ($248 Mil).

Teleflex Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Teleflex's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teleflex Current Accrued Expense Chart

Teleflex Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 312.31 279.07 299.00 215.01 247.52

Teleflex Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 276.98 331.55 247.52 238.25 247.94
TFX
73GF Score
Teleflex Inc TFX
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teleflex Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $248 Mil mean?
Teleflex (TFX) has a Current Accrued Expense of $248 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Teleflex and its competitors.
Is Teleflex's Current Accrued Expense too high?
Teleflex's current Current Accrued Expense is $248 Mil. Overall, Teleflex has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Teleflex's Current Accrued Expense compare to STVN and MMED?
Teleflex's Current Accrued Expense of $248 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Devices & Instruments company?
A good Current Accrued Expense depends on the Medical Devices & Instruments industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Teleflex and its competitors. Teleflex's current Current Accrued Expense is $248 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teleflex stock overvalued right now?
Based on GuruFocus' analysis, Teleflex (TFX) is currently considered Modestly Undervalued. The stock's GF Value™ is $173.20, compared to a current price of $142.66 — trading 17.6% below its estimated fair value. The current Current Accrued Expense is $248 Mil. Teleflex's overall GF Score™ is 73/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Teleflex (TFX), the current Current Accrued Expense is $248 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Teleflex (TFX) Overvalued in 2026?

Based on GuruFocus' analysis, Teleflex stock appears to be undervalued. The current stock price of $142.66 is trading 17.6% below its estimated GF Value™ of $173.20. GuruFocus considers Teleflex to be Modestly Undervalued.

Key valuation signals for TFX:

  • Current Accrued Expense: $248 Mil
  • GF Value™: $173.20 vs. price of $142.66 (17.6% below fair value)
  • GF Score™: 73/100 with 9 warning signs

No single metric tells the full story. See the TFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Teleflex Business Description

Other Exchanges 1TFX:ItalyTBH:Germany
Address 550 East Swedesford Road, Suite 400, Wayne, PA, USA, 19087
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
73GF Score

Get the complete analysis for TFX

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$142.66
Price
$173.20
GF Value